Compliance Rate
Compliance Rate
50.0%
Compliant submissions
1
Incompliant submissions
1
Total trials
2
My Organizations' Clinical Trials
Showing 475 of 814 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 12/01/24
Due: 12/01/25
Phase: N/A
Priority: Normal
Start: 11/22/21
End: 07/31/26
Due: 07/31/27
Phase: N/A
Priority: Normal
Start: 12/13/17
End: 04/10/18
Due: 04/10/19
Phase: N/A
Priority: Normal
Start: 06/14/23
End: 06/01/25
Due: 06/01/26
Phase: N/A
Priority: Normal
Start: 03/01/27
End: 03/01/30
Due: 03/01/31
Phase: N/A
Priority: Normal
Start: 02/28/10
End: 02/29/12
Due: 02/28/13
Phase: N/A
Priority: Normal
Start: 01/10/24
End: 10/10/24
Due: 10/10/25
Phase: N/A
Priority: Normal
Start: 09/07/22
End: 10/19/23
Due: 10/19/24
Phase: N/A
Priority: Normal
Start: 10/01/22
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 01/01/19
End: 01/01/28
Due: 01/01/29
Phase: N/A
Priority: Normal
Start: 12/31/16
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/02/12
End: 03/30/16
Due: 03/30/17
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 04/13/17
Due: 04/13/18
Phase: N/A
Priority: Normal
Start: 10/09/18
End: 01/02/22
Due: 01/02/23
Phase: N/A
Priority: Normal
Start: 06/14/21
End: 01/01/26
Due: 01/01/27
Phase: N/A
Priority: Normal
Start: 05/01/17
End: 08/31/28
Due: 08/31/29
Phase: N/A
Priority: Normal
Start: 12/31/18
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 12/31/16
End: 07/31/21
Due: 07/31/22
Phase: N/A
Priority: Normal
Start: 02/18/25
End: 08/31/29
Due: 08/31/30
Phase: N/A
Priority: Normal
Start: 01/19/21
End: 12/31/22
Due: 12/31/23
Phase: N/A
Priority: Normal
Start: 07/31/94
End: 05/31/09
Due: 05/31/10
Phase: N/A
Priority: Normal
Start: 03/26/24
End: 05/10/24
Due: 05/10/25
Pentosan Polysulfate Sodium and Meclofenamic Acid as Treatments in Patients With Psychotic Disorders
Phase: N/A
Priority: Normal
Start: 08/07/15
End: 10/06/16
Due: 10/06/17
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 05/31/19
Due: 05/31/20
Phase: N/A
Priority: Normal
Start: 12/31/16
End: 07/31/21
Due: 07/31/22